Optas LLC
RVMD icon

Optas LLC’s Revolution Medicines RVMD Stock Holding History

Optas LLC’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$203K Buy
+989
New +$196K 0.03% 436

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Optas LLC's RVMD Position: Q3 2026 in Review

Optas LLC opened a new position in Revolution Medicines (RVMD) in Q3 2026: 989 shares worth $203K. The stake represents 0.03% of the portfolio and ranks #436 among its holdings.

405 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Optas LLC held 989 shares of Revolution Medicines worth $203K as of Q3 2026.
  • Revolution Medicines was a new Optas LLC position in Q3 2026.
  • Revolution Medicines made up 0.03% of Optas LLC's portfolio in Q3 2026, its #436 holding.
  • 405 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Optas LLC's 13F filing for Q3 2026, filed 9 Nov 2026.